Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rEMS and PRP in Retinitis Pigmentosa
NCT04252534Completed
- Sponsor
- Ankara Üniversitesi Teknokent
- Start
- Jan 2017
- Primary completion
- Dec 2019
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
01
Overview
Open-label trial of platelet-rich plasma in retinitis pigmentosa (RP) (3 arms), sponsored by Ankara Üniversitesi Teknokent. Primary endpoint: Ellipsoid zone width at 12 months. Started Jan 2017; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on NCT04252534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04252534.